Tecfidera ( BG-12 ) FDA-Approved
Great news! The third oral treatment for relapsing MS has now been FDA-approved. Tecfidera is a twice a day oral agent that has been shown to reduce new MS exacerbations by 44-53% in two large clinical trials.
BY: Barry Singer, MD DATE: March 28, 2013 TOPIC: MS Research News